propranolol has been researched along with Substance Withdrawal Syndrome in 231 studies
Propranolol: A widely used non-cardioselective beta-adrenergic antagonist. Propranolol has been used for MYOCARDIAL INFARCTION; ARRHYTHMIA; ANGINA PECTORIS; HYPERTENSION; HYPERTHYROIDISM; MIGRAINE; PHEOCHROMOCYTOMA; and ANXIETY but adverse effects instigate replacement by newer drugs.
propranolol : A propanolamine that is propan-2-ol substituted by a propan-2-ylamino group at position 1 and a naphthalen-1-yloxy group at position 3.
Substance Withdrawal Syndrome: Physiological and psychological symptoms associated with withdrawal from the use of a drug after prolonged administration or habituation. The concept includes withdrawal from smoking or drinking, as well as withdrawal from an administered drug.
| Excerpt | Relevance | Reference |
|---|---|---|
| "The effect of the withdrawal of long-term beta-adrenoceptor blockade on pulse rate and finger tremor was studied in 27 patients who had been treated for 2 years following an uncomplicated myocardial infarction with either atenolol, propranolol or placebo." | 9.05 | Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol. ( Birmingham, AT; Roland, JM; Wharrad, HJ; Williams, EJ; Wilson, CG, 1984) |
| "The potential hazards of abrupt withdrawal of propranolol have been described in patients with angina pectoris; however, the effects of abrupt withdrawal from long-term therapy with verapamil have not previously been investigated." | 9.05 | Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectoris. ( Cohen, MN; Frishman, WH; Iorio, L; Klein, N; Klein, P; LeJemtel, T; Pollack, S; Roth, S; Shamoon, H; Sonnenblick, EH; Strom, J; Willens, H, 1982) |
| "The effect of the beta-adrenergic blocking agent propranolol was tested on positional tremor occurring during acute alcohol withdrawal using a double-blind crossover method and electrical recording of tremor amplitude and frequency." | 9.04 | Effect of propranolol on acute withdrawal tremor in alcoholic patients. ( Larsen, A; Teräväinen, H, 1976) |
| "The aims of the study were to characterize the rate and extent of the rebound effect after abrupt cessation of a chronic exposure of l-propranolol in spontaneous hypertensive rats, using exercise-induced tachycardia as a pharmacodynamic endpoint." | 7.70 | Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats. ( Brynne, L; Karlsson, MO; Paalzow, LK, 1999) |
| "Antiarrhythmic effects of cordarone, ethacizine, and obsidan were evaluated in 30 patients with chronic alcoholism in whom premature ventricular contractions were recorded at a rate of at least of 5 per minute by 30-minute ECG monitoring when they were admitted to a narcologic hospital, having the alcohol withdrawal syndrome." | 7.68 | [Effectiveness of single intravenous administration of cordarone, ethacizine and obsidan in ventricular extrasystole in patients with chronic alcoholism during withdrawal]. ( Gorgaslidze, AG; Karaush, AP; Smetnev, AS, 1991) |
| "The effects of nine calcium ion antagonists on exercise tolerance, heart rate and ST-segment changes were compared with those of propranolol in two hundred and eighty patients with established chronic stable angina pectoris." | 7.67 | A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris. ( Khurmi, NS; Raftery, EB, 1987) |
| "The tremorogenic effect of nicotine was studied in control rats and in rats withdrawn for 16-48 h from six to nine days' ethanol administration." | 7.67 | Ethanol withdrawal tremor potentiates the tremorogenic action of nicotine. ( Gothóni, P; Ikola, W, 1985) |
| " Seven days later, the animals were challenged with a dose of isoproterenol which would produce massive myocardial infarction and 50-60% mortality in non-treated animals." | 7.67 | Prolonged protective effects following propranolol withdrawal against isoproterenol-induced myocardial infarction in normotensive and hypertensive rats. ( Wexler, BC, 1985) |
| " Also, the influence of propranolol withdrawal on vulnerability to aconitine-induced arrhythmias in vivo was evaluated in anesthetized rats." | 7.66 | Sustained cardiac beta adrenoceptor blockade in vitro and increased vulnerability to aconitine-induced arrhythmias in vivo after propranolol withdrawal in rats. ( Hedberg, A; Isaksson, O; Lundgren, B, 1980) |
| "The hemodynamic mechanism of the hypotensive effect of propranolol was studied by quantitative radiocardiography in 8 patients with dialysis-resistant hypertension." | 7.66 | Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension. ( Contini, C; Maggiore, Q; Monzani, G; Zoccali, C, 1978) |
| "The effect of abrupt withdrawal of propranolol on serum concentrations of triiodothyronine (T3) and thyroxine (T4) was investigated in 5 patients with uncomplicated essential hypertension." | 7.66 | Propranolol withdrawal and thyroid hormones in patients with essential hypertension. ( Kristensen, BO; Steiness, E; Weeke, J, 1978) |
| "3 years) with angina pectoris had propranolol abruptly discontinued 24 to 144 hours (mean 39." | 7.66 | Propranolol withdrawal in angina pectoris: a prospective study. ( Freeman, MR; Juma, ZA; Myers, MG; Wisenberg, G, 1979) |
| "Sclerosing peritonitis developed in a 56-year-old white man who had been receiving propranolol (320 mg/day) for hypertension and angina pectoris since December 1976." | 7.66 | Sclerosing peritonitis and propranolol. ( Ahmad, S, 1981) |
| "The tremorogenic effect of nicotine was studied in control rats and in rats withdrawn for 16-48 h from chronic ethanol administration." | 7.66 | Hypersensitivity to the tremorogenic action of nicotine in rats withdrawn from ethanol. ( Gothóni, P, 1983) |
| "Blood thyroid hormone levels were measured during, and for 6 days after, treatment with propranolol (160 mg/day, 4-8 weeks) in five hyperthyroid patients and six normal volunteers." | 7.66 | The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects. ( John, R; Jones, MK; Ross, PJ, 1980) |
| "The pattern of cardiac arrhythmias and their treatment, by propranolol and chlordiazepoxide, during the first 48 hr of alcohol withdrawal has been studied." | 7.66 | Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal. ( Jacob, MS; MacLeod, SM; Sellers, EM; Ti, TY; Zilm, DH, 1980) |
| "On 51 of 53 occasions, sudden withdrawal of propranolol from patients with angina pectoris produced no substantial adverse effects." | 7.65 | Sudden withdrawal of propranolol in patients with angina pectoris. ( Myers, MG; Wisenberg, G, 1977) |
| " Clinically, propranolol, an agent of this group, has been investigated in the treatment of various clinical disorders including schizophrenia, other psychoses, anxiety disorders, and stress reactions." | 6.15 | Propranolol in psychiatry. Therapeutic uses and side effects. ( Ananth, J; Lin, KM, 1986) |
| "Infantile hemangiomas are the most common vascular tumors in childhood." | 5.42 | Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report. ( del Boz González, J; Navarro Morón, J; Porcel Chacón, R, 2015) |
| "The effect of the withdrawal of long-term beta-adrenoceptor blockade on pulse rate and finger tremor was studied in 27 patients who had been treated for 2 years following an uncomplicated myocardial infarction with either atenolol, propranolol or placebo." | 5.05 | Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol. ( Birmingham, AT; Roland, JM; Wharrad, HJ; Williams, EJ; Wilson, CG, 1984) |
| "The potential hazards of abrupt withdrawal of propranolol have been described in patients with angina pectoris; however, the effects of abrupt withdrawal from long-term therapy with verapamil have not previously been investigated." | 5.05 | Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectoris. ( Cohen, MN; Frishman, WH; Iorio, L; Klein, N; Klein, P; LeJemtel, T; Pollack, S; Roth, S; Shamoon, H; Sonnenblick, EH; Strom, J; Willens, H, 1982) |
| "The effect of the beta-adrenergic blocking agent propranolol was tested on positional tremor occurring during acute alcohol withdrawal using a double-blind crossover method and electrical recording of tremor amplitude and frequency." | 5.04 | Effect of propranolol on acute withdrawal tremor in alcoholic patients. ( Larsen, A; Teräväinen, H, 1976) |
| " Pertinent history revealed that he took drugs containing triiodothyronine (64 mug) and propranolol (40 mg) twice daily for weight reduction in the past month and discontinued these drugs 3 days before admission." | 3.75 | An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents. ( Chou, HK; Lin, SH; Tsao, YT, 2009) |
| "The aims of the study were to characterize the rate and extent of the rebound effect after abrupt cessation of a chronic exposure of l-propranolol in spontaneous hypertensive rats, using exercise-induced tachycardia as a pharmacodynamic endpoint." | 3.70 | Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats. ( Brynne, L; Karlsson, MO; Paalzow, LK, 1999) |
| "Antiarrhythmic effects of cordarone, ethacizine, and obsidan were evaluated in 30 patients with chronic alcoholism in whom premature ventricular contractions were recorded at a rate of at least of 5 per minute by 30-minute ECG monitoring when they were admitted to a narcologic hospital, having the alcohol withdrawal syndrome." | 3.68 | [Effectiveness of single intravenous administration of cordarone, ethacizine and obsidan in ventricular extrasystole in patients with chronic alcoholism during withdrawal]. ( Gorgaslidze, AG; Karaush, AP; Smetnev, AS, 1991) |
| "The effects of nine calcium ion antagonists on exercise tolerance, heart rate and ST-segment changes were compared with those of propranolol in two hundred and eighty patients with established chronic stable angina pectoris." | 3.67 | A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris. ( Khurmi, NS; Raftery, EB, 1987) |
| "The tremorogenic effect of nicotine was studied in control rats and in rats withdrawn for 16-48 h from six to nine days' ethanol administration." | 3.67 | Ethanol withdrawal tremor potentiates the tremorogenic action of nicotine. ( Gothóni, P; Ikola, W, 1985) |
| " Seven days later, the animals were challenged with a dose of isoproterenol which would produce massive myocardial infarction and 50-60% mortality in non-treated animals." | 3.67 | Prolonged protective effects following propranolol withdrawal against isoproterenol-induced myocardial infarction in normotensive and hypertensive rats. ( Wexler, BC, 1985) |
| "The effects of placebo, propranolol, and clonidine on blood pressure and blood pressure variability were examined in 14 subjects who had moderate essential hypertension." | 3.67 | Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine. ( Lowenstein, J; Neusy, AJ, 1989) |
| "Blood thyroid hormone levels were measured during, and for 6 days after, treatment with propranolol (160 mg/day, 4-8 weeks) in five hyperthyroid patients and six normal volunteers." | 3.66 | The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects. ( John, R; Jones, MK; Ross, PJ, 1980) |
| "A patient developed severe anxiety, moodswing, depression, and thinking disorder 24 hours after abruptly stopping oxazepam, of which he had taken 30 mg 3 times a day for two months, for anxiety and panic attacks." | 3.66 | Abstinence syndrome from therapeutic doses of oxazepam. ( Kulik, AV; Wilbur, R, 1983) |
| "Sclerosing peritonitis developed in a 56-year-old white man who had been receiving propranolol (320 mg/day) for hypertension and angina pectoris since December 1976." | 3.66 | Sclerosing peritonitis and propranolol. ( Ahmad, S, 1981) |
| "The pattern of cardiac arrhythmias and their treatment, by propranolol and chlordiazepoxide, during the first 48 hr of alcohol withdrawal has been studied." | 3.66 | Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal. ( Jacob, MS; MacLeod, SM; Sellers, EM; Ti, TY; Zilm, DH, 1980) |
| "3 years) with angina pectoris had propranolol abruptly discontinued 24 to 144 hours (mean 39." | 3.66 | Propranolol withdrawal in angina pectoris: a prospective study. ( Freeman, MR; Juma, ZA; Myers, MG; Wisenberg, G, 1979) |
| "The effect of abrupt withdrawal of propranolol on serum concentrations of triiodothyronine (T3) and thyroxine (T4) was investigated in 5 patients with uncomplicated essential hypertension." | 3.66 | Propranolol withdrawal and thyroid hormones in patients with essential hypertension. ( Kristensen, BO; Steiness, E; Weeke, J, 1978) |
| "The hemodynamic mechanism of the hypotensive effect of propranolol was studied by quantitative radiocardiography in 8 patients with dialysis-resistant hypertension." | 3.66 | Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension. ( Contini, C; Maggiore, Q; Monzani, G; Zoccali, C, 1978) |
| " Also, the influence of propranolol withdrawal on vulnerability to aconitine-induced arrhythmias in vivo was evaluated in anesthetized rats." | 3.66 | Sustained cardiac beta adrenoceptor blockade in vitro and increased vulnerability to aconitine-induced arrhythmias in vivo after propranolol withdrawal in rats. ( Hedberg, A; Isaksson, O; Lundgren, B, 1980) |
| "The tremorogenic effect of nicotine was studied in control rats and in rats withdrawn for 16-48 h from chronic ethanol administration." | 3.66 | Hypersensitivity to the tremorogenic action of nicotine in rats withdrawn from ethanol. ( Gothóni, P, 1983) |
| "On 51 of 53 occasions, sudden withdrawal of propranolol from patients with angina pectoris produced no substantial adverse effects." | 3.65 | Sudden withdrawal of propranolol in patients with angina pectoris. ( Myers, MG; Wisenberg, G, 1977) |
| "Propranolol treated subjects had lower cocaine withdrawal symptom severity but otherwise did not differ from placebo treated subjects in any outcome measure." | 2.70 | Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity. ( Acosta, T; Alterman, AI; Cnaan, A; Cornish, J; Gariti, P; Kampman, KM; Luce, D; Muller, E; Mulvaney, F; O'Brien, C; Poole, S; Volpicelli, JR, 2001) |
| "Patients in the SW group had only mild withdrawal symptoms, while those in the PW group suffered more severe symptoms, which lasted around four weeks." | 2.67 | Chronic benzodiazepine dependence. A comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal. ( Cantopher, T; Cleave, N; Edwards, JG; Olivieri, S, 1990) |
| "Thus, beta-blocker withdrawal symptoms are reproducible and are indicative of a transient sympathetic hyperresponse." | 2.65 | Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin. ( Christensen, NJ; Lanng Nielsen, J; Lederballe Pedersen, O; Mikkelsen, E, 1979) |
| " Tapering propranolol dosage is frequently used in the hope of preventing adverse withdrawal events but the success of such a maneuver has not been shown." | 2.65 | Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule. ( Lutterodt, A; Nattel, S; Rangno, RE, 1982) |
| "40 patients seen in general practice and psychiatric outpatient clinics who had taken lorazepam or diazepam alone in regular dosage for a mean period of 3." | 2.65 | Benzodiazepine withdrawal symptoms and propranolol. ( Huggett, T; Rutherford, D; Tyrer, P, 1981) |
| " The dosage should be reduced gradually, particularly the final decrement." | 2.36 | The beta-adrenergic blockade withdrawal phenomenon. ( Bhattacharjee, P; Prichard, BN; Tomlinson, B; Walden, RJ, 1983) |
| "Infantile hemangiomas are the most common vascular tumors in childhood." | 1.42 | Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report. ( del Boz González, J; Navarro Morón, J; Porcel Chacón, R, 2015) |
| "Morphine withdrawal was precipitated on day 8 by the injection of naloxone (2 mg/kg s." | 1.38 | Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal-regulated kinase. ( Almela, P; Hurle, MA; Laorden, ML; Martínez-Laorden, E; Milanés, MV, 2012) |
| "Following development of alcohol dependence, rats exhibit hypersensitivity to the suppressive effects of propranolol on operant alcohol-reinforced responding." | 1.36 | Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats. ( Gilpin, NW; Koob, GF, 2010) |
| "Research has shown that enhancement of cannabinoid CB(1) receptor activity elicits an antidepressant-like response in the forced swim test (FST); however, the effects of chronic administration of cannabinoid agents in the FST are not well characterized." | 1.35 | Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission. ( Gorzalka, BB; Hill, MN; Morrish, AC; Riebe, CJ, 2009) |
| "Morphine withdrawal was precipitated by administration of naloxone (5 mg/kg subcutaneously) on day 8." | 1.32 | Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors. ( Aviles, M; González-Cuello, A; Laorden, ML; Milanés, MV, 2004) |
| " This might result from an increased bioavailability of propranolol on day 1 and from marked sympathetic activity." | 1.32 | Alcohol withdrawal changes cardiovascular responses to propranolol challenge. ( Kähkönen, S, 2003) |
| "4." | 1.29 | Study of the mechanisms involved in behavioral changes induced by flunitrazepam in morphine withdrawal. ( Gibert-Rahola, J; Maldonado, R; Micó, JA; Valverde, O, 1995) |
| " 5 Clinically important changes in drug effect may be present acutely, within the dosing interval, as a result of altered drug binding." | 1.27 | Variations in drug free fraction during alcohol withdrawal. ( Khouw, V; Naranjo, CA; Sandor, P; Sellers, EM, 1983) |
| "Barbital was applied on a schedule of gradually increasing dosages from 0." | 1.27 | Effects of propranolol on barbital dependence formation and withdrawal signs. ( Hiramori, T; Nakao, K; Tagashira, E; Urano, T; Yanaura, S, 1983) |
| " Dose-response curves and geometric mean ED50 values revealed the presence of supersensitivity to the chronotropic and inotropic effects of isoproterenol in vitro at 72 and 96 h after withdrawal." | 1.27 | Propranolol withdrawal supersensitivity in rat cardiovascular tissue, in vitro. ( Tenner, TE, 1983) |
| "Pretreatment with propranolol completely prevented rebound hemodynamic events after nitroprusside." | 1.27 | Propranolol prevents hemodynamic and humoral events after abrupt withdrawal of nitroprusside. ( Battit, GE; Fahmy, NR; Lappas, DG; Mihelakos, PT, 1984) |
| " These patients are best managed as outpatients with gradual dosage reduction over 4-12 weeks." | 1.27 | Management of benzodiazepine dependence. ( Lader, M; Moodley, P, 1986) |
| " Dose-response curves were obtained one week prior to pretreatment and 24, 48, 72 and 168 hours after the last dose of propranolol." | 1.27 | Propranolol withdrawal-induced supersensitivity to the chronotropic effects of isoproterenol in the conscious rabbit. ( Tenner, TE, 1983) |
| "The effect is critically reviewed of chronic administration of beta-adrenoreceptor antagonists on morbidity and mortality in angina pectoris and myocardial infarction." | 1.26 | The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease. ( Fitzgerald, JD, 1976) |
| "Propranolol alone was more effective than either chlordiazepoxide or a combination of chlordiazepoxide and propranolol in alleviating the symptoms of the alcohol withdrawal syndrome." | 1.26 | Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal. ( Degani, NC; Sellers, EM; Zilm, DH, 1977) |
| "Abrupt withdrawal after the chronic administration of propranolol has resulted in clinical syndromes that suggest adrenergic hypersensitivity." | 1.26 | Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration. ( Aarons, RD; Gal, J; Hegstrand, LR; Molinoff, PB; Nies, AS, 1980) |
| "The major reason for treating hypertension is to avoid complications of the disease as it affects "target organs." | 1.26 | Prevention of some complications of essential hypertension. ( Grissom, RL; Gust, WF, 1977) |
| "Propranolol hydrochloride was administered to 21 healthy subjects for 15 days." | 1.26 | Abrupt propranolol withdrawal and myocardial contractility. A study of effects in normal man. ( Lee, YC; Pantano, JA, 1976) |
| "When propranolol and morphine were administered concurrently the morphine ED50 (on day 5) was twice that of the group receiving morphine alone." | 1.25 | Effect of propranolol on antinociceptive, tolerance- and dependence-producing properties of morphine in rodents and monkeys. ( Cowan, A; Macfarlane, IR, 1975) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 187 (80.95) | 18.7374 |
| 1990's | 21 (9.09) | 18.2507 |
| 2000's | 14 (6.06) | 29.6817 |
| 2010's | 9 (3.90) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Snyder, AE | 1 |
| Salimando, GJ | 1 |
| Winder, DG | 1 |
| Silberman, Y | 1 |
| Ortiz, V | 1 |
| Giachero, M | 1 |
| Espejo, PJ | 1 |
| Molina, VA | 1 |
| Martijena, ID | 1 |
| Porcel Chacón, R | 1 |
| del Boz González, J | 1 |
| Navarro Morón, J | 1 |
| Kelley, BJ | 1 |
| Yeager, KR | 1 |
| Pepper, TH | 1 |
| Bornstein, RA | 1 |
| Beversdorf, DQ | 1 |
| Chou, HK | 1 |
| Tsao, YT | 1 |
| Lin, SH | 1 |
| Morrish, AC | 1 |
| Hill, MN | 1 |
| Riebe, CJ | 1 |
| Gorzalka, BB | 1 |
| Rothwell, PE | 1 |
| Thomas, MJ | 1 |
| Gewirtz, JC | 1 |
| Gilpin, NW | 1 |
| Koob, GF | 1 |
| Bruijnzeel, AW | 1 |
| Bishnoi, M | 1 |
| van Tuijl, IA | 1 |
| Keijzers, KF | 1 |
| Yavarovich, KR | 1 |
| Pasek, TM | 1 |
| Ford, J | 1 |
| Alexander, JC | 1 |
| Yamada, H | 1 |
| Zhang, XL | 1 |
| Shi, J | 1 |
| Zhao, LY | 1 |
| Sun, LL | 1 |
| Wang, J | 1 |
| Wang, GB | 1 |
| Epstein, DH | 1 |
| Lu, L | 1 |
| de Oliveira Citó, Mdo C | 1 |
| da Silva, FC | 1 |
| Silva, MI | 1 |
| Moura, BA | 1 |
| Macêdo, DS | 1 |
| Woods, DJ | 1 |
| Fonteles, MM | 1 |
| de Vasconcelos, SM | 1 |
| de Sousa, FC | 1 |
| Wu, Y | 1 |
| Li, Y | 1 |
| Yang, X | 1 |
| Sui, N | 1 |
| Martínez-Laorden, E | 1 |
| Hurle, MA | 1 |
| Milanés, MV | 2 |
| Laorden, ML | 2 |
| Almela, P | 1 |
| Watanabe, T | 1 |
| Nakagawa, T | 1 |
| Yamamoto, R | 1 |
| Maeda, A | 1 |
| Minami, M | 1 |
| Satoh, M | 1 |
| Kähkönen, S | 2 |
| Castro, VJ | 1 |
| González-Cuello, A | 1 |
| Aviles, M | 1 |
| Kampman, KM | 3 |
| Dackis, C | 1 |
| Lynch, KG | 1 |
| Pettinati, H | 1 |
| Tirado, C | 1 |
| Gariti, P | 2 |
| Sparkman, T | 1 |
| Atzram, M | 1 |
| O'Brien, CP | 1 |
| Bondarenko, B | 1 |
| Lipsanen, J | 1 |
| Zvartau, E | 1 |
| Zawad, JS | 1 |
| Brown, FC | 1 |
| Kiyingi, KS | 1 |
| Shaw, J | 1 |
| Aarons, RD | 1 |
| Nies, AS | 2 |
| Gal, J | 1 |
| Hegstrand, LR | 1 |
| Molinoff, PB | 1 |
| Tyrer, P | 2 |
| Rutherford, D | 1 |
| Huggett, T | 1 |
| Hart, GR | 1 |
| Anderson, RJ | 1 |
| Obukhov, GA | 1 |
| Henderson, A | 1 |
| Sheridan, D | 1 |
| Ross, J | 1 |
| Lewis, M | 1 |
| Walden, RJ | 5 |
| Hernandez, J | 1 |
| Yu, Y | 1 |
| Al-Khader, A | 1 |
| Prichard, BN | 5 |
| Rangno, RE | 6 |
| Langlois, S | 2 |
| Bhattacharjee, P | 3 |
| Tomlinson, B | 3 |
| Kurlan, R | 1 |
| Shoulson, I | 1 |
| Murrin, LC | 1 |
| Kennedy, RH | 1 |
| Donnelly, TE | 1 |
| Belanová, M | 1 |
| Inczinger, F | 1 |
| Johnson, JM | 1 |
| Krämer, B | 1 |
| Kübler, W | 1 |
| Goliakov, VN | 1 |
| Zimin, IuV | 1 |
| Dominguez, RA | 1 |
| Goldstein, BJ | 1 |
| Seivewright, N | 1 |
| Tyrer, PJ | 1 |
| Kistler, K | 1 |
| Davis, JN | 1 |
| Hedberg, A | 1 |
| Isaksson, O | 1 |
| Lundgren, B | 1 |
| Kobayashi, A | 1 |
| Ogawa, K | 1 |
| Yamazaki, N | 1 |
| Nattel, S | 3 |
| Lutterodt, A | 1 |
| Tenner, TE | 2 |
| Giudicelli, Y | 1 |
| Lacasa, D | 1 |
| Agli, B | 1 |
| Leneveu, A | 1 |
| Cramb, G | 1 |
| Griffiths, NM | 1 |
| Aiton, JF | 1 |
| Simmons, NL | 1 |
| Fahmy, NR | 1 |
| Mihelakos, PT | 1 |
| Battit, GE | 1 |
| Lappas, DG | 1 |
| Wharrad, HJ | 1 |
| Birmingham, AT | 1 |
| Wilson, CG | 1 |
| Williams, EJ | 1 |
| Roland, JM | 1 |
| Gauché, WG | 1 |
| Alabaster, SL | 1 |
| Gogel, HK | 1 |
| McCarthy, DM | 1 |
| Tagashira, E | 2 |
| Hiramori, T | 2 |
| Nakao, K | 2 |
| Urano, T | 2 |
| Yanaura, S | 2 |
| Lorenz, D | 1 |
| Smolinsky, A | 1 |
| Ziskind, Z | 1 |
| Goor, DA | 1 |
| Gothóni, P | 2 |
| Smile, DH | 1 |
| Yudofsky, SC | 1 |
| Stevens, L | 1 |
| Silver, J | 1 |
| Barsa, J | 1 |
| Williams, D | 1 |
| Wilkinson, CJ | 1 |
| Sanders, JH | 1 |
| Halawa, B | 1 |
| Frishman, WH | 1 |
| Klein, N | 1 |
| Strom, J | 2 |
| Cohen, MN | 1 |
| Shamoon, H | 1 |
| Willens, H | 1 |
| Klein, P | 1 |
| Roth, S | 1 |
| Iorio, L | 1 |
| LeJemtel, T | 1 |
| Pollack, S | 1 |
| Sonnenblick, EH | 1 |
| Sandor, P | 1 |
| Naranjo, CA | 1 |
| Khouw, V | 1 |
| Sellers, EM | 9 |
| Stiff, JL | 1 |
| Harris, DB | 1 |
| Wilbur, R | 1 |
| Kulik, AV | 1 |
| Jacob, MS | 2 |
| Zilm, DH | 6 |
| MacLeod, SM | 4 |
| Ahmad, S | 2 |
| Lebrec, D | 2 |
| Bernuau, J | 1 |
| Rueff, B | 1 |
| Benhamou, JP | 1 |
| Ti, TY | 1 |
| Hodding, GC | 1 |
| Jann, M | 1 |
| Ackerman, IP | 1 |
| Katerndahl, DA | 1 |
| Gross, GA | 1 |
| Waddingham, S | 1 |
| Belknap, JK | 1 |
| Samanin, R | 1 |
| Cervo, L | 1 |
| Rochat, C | 1 |
| Poggesi, E | 1 |
| Mennini, T | 1 |
| Dennis, SC | 1 |
| Manning, AS | 1 |
| Hearse, DJ | 1 |
| Coltart, DJ | 2 |
| Hemmingsen, R | 2 |
| Holm-Jensen, J | 1 |
| Trojaborg, W | 1 |
| Stolz, JF | 1 |
| Marsden, CA | 1 |
| Abernethy, DR | 1 |
| Greenblatt, DJ | 1 |
| Shader, RI | 1 |
| Schwartz, J | 1 |
| Jackson, G | 1 |
| Kates, RE | 2 |
| Harrison, DC | 3 |
| Telichowski, C | 1 |
| Przybył, F | 1 |
| Rachwalik, M | 1 |
| Lacheta, W | 1 |
| Ross, PJ | 3 |
| Jones, MK | 1 |
| John, R | 1 |
| Goldman, L | 1 |
| Harris, GC | 2 |
| Aston-Jones, G | 4 |
| Roy-Byrne, PP | 1 |
| Sullivan, MD | 1 |
| Cowley, DS | 1 |
| Ries, RK | 1 |
| Chakrabarti, A | 1 |
| Sharma, PL | 1 |
| Valverde, O | 1 |
| Maldonado, R | 1 |
| Micó, JA | 1 |
| Gibert-Rahola, J | 1 |
| Zarrindast, MR | 2 |
| Farzin, D | 1 |
| Rezayat, M | 1 |
| Azizi, N | 1 |
| Bato, K | 1 |
| Fukunaga, Y | 1 |
| Fukuzaki, M | 1 |
| Kawahata, K | 1 |
| Brynne, L | 1 |
| Paalzow, LK | 1 |
| Karlsson, MO | 1 |
| Delfs, JM | 2 |
| Druhan, J | 1 |
| Zhu, Y | 2 |
| Druhan, JP | 1 |
| Bento, MS | 1 |
| Esperança, P | 1 |
| Volpicelli, JR | 1 |
| Mulvaney, F | 1 |
| Alterman, AI | 1 |
| Cornish, J | 1 |
| Cnaan, A | 1 |
| Poole, S | 1 |
| Muller, E | 1 |
| Acosta, T | 1 |
| Luce, D | 1 |
| O'Brien, C | 1 |
| Cowan, A | 1 |
| Macfarlane, IR | 1 |
| Fitzgerald, JD | 1 |
| Rosei, EA | 1 |
| Brown, JJ | 1 |
| Fraser, R | 1 |
| Lever, AF | 1 |
| Morton, JJ | 1 |
| Robertson, JI | 1 |
| Trust, PM | 1 |
| Snyder, SH | 1 |
| Frishman, W | 3 |
| Silverman, R | 1 |
| Elkayam, U | 1 |
| Sonnenblick, E | 1 |
| Lederballe Pedersen, O | 2 |
| Mikkelsen, E | 2 |
| Lanng Nielsen, J | 1 |
| Christensen, NJ | 1 |
| Jacob, H | 1 |
| Eisenberg, E | 1 |
| Ribner, H | 1 |
| Lewis, MJ | 2 |
| Henderson, AH | 2 |
| Liljequist, S | 1 |
| Engel, J | 1 |
| Degani, NC | 2 |
| Resnick, RB | 1 |
| Kestenbaum, RS | 1 |
| Schwartz, LK | 2 |
| Smith, A | 1 |
| O'Brien, ET | 2 |
| Kristensen, BO | 4 |
| Boudoulas, H | 4 |
| Lewis, RP | 2 |
| Dalamangas, G | 1 |
| French, SW | 2 |
| Palmer, DS | 2 |
| Wiggers, KD | 1 |
| Gerber, JG | 1 |
| Dollery, CT | 2 |
| Maling, TJ | 2 |
| Salazar, C | 1 |
| Friedman, S | 1 |
| Patel, J | 1 |
| Lin, YT | 1 |
| Oka, Y | 1 |
| Frater, RW | 1 |
| Becker, RM | 1 |
| Snyder, GL | 1 |
| Karayannacos, P | 1 |
| Vasko, JS | 1 |
| Myers, MG | 2 |
| Freeman, MR | 1 |
| Juma, ZA | 1 |
| Wisenberg, G | 2 |
| Frecker, RC | 1 |
| Kunov, H | 1 |
| Van Loon, G | 1 |
| Sheikh, AI | 1 |
| Meeran, MK | 1 |
| Vernon, C | 1 |
| Sakula, A | 1 |
| Offerhaus, L | 1 |
| Steiness, E | 2 |
| Weeke, J | 2 |
| Freund, G | 1 |
| Myers, JH | 1 |
| Horwitz, LD | 1 |
| Barry, DI | 1 |
| Hertz, MM | 1 |
| Klinken, L | 1 |
| Danilevicius, Z | 1 |
| Shenkman, L | 1 |
| Podrid, P | 1 |
| Lowenstein, J | 2 |
| Strauss, FG | 1 |
| Franklin, SS | 1 |
| Lewin, AJ | 1 |
| Maxwell, MH | 1 |
| Penhall, RK | 1 |
| Frewin, DB | 1 |
| Weber, MA | 1 |
| Wood, AJ | 2 |
| Shand, DG | 3 |
| Shiroff, RA | 1 |
| Mathis, J | 1 |
| Zelis, R | 1 |
| Schneck, DW | 1 |
| Babb, JD | 1 |
| Leaman, DM | 1 |
| Hayes, AH | 1 |
| Chrysant, SG | 1 |
| Whitsett, TL | 1 |
| Vaisrub, S | 1 |
| Maggiore, Q | 1 |
| Zoccali, C | 1 |
| Monzani, G | 1 |
| Contini, C | 1 |
| Robertson, CC | 1 |
| Shanks, J | 1 |
| Teräväinen, H | 1 |
| Larsen, A | 1 |
| Carlsson, C | 2 |
| Spodick, DH | 1 |
| Grissom, RL | 1 |
| Gust, WF | 1 |
| Mizgala, HF | 1 |
| Counsell, J | 1 |
| Drawbaugh, RB | 1 |
| Lal, H | 1 |
| Bennett, KR | 1 |
| Pantano, JA | 1 |
| Lee, YC | 1 |
| Jacob, RG | 1 |
| Holmstrand, J | 1 |
| Eriksson, JH | 1 |
| Anggård, E | 1 |
| Miller, RR | 1 |
| Olson, HG | 1 |
| Amsterdam, EA | 1 |
| Mason, DT | 1 |
| Pettinger, WA | 1 |
| Allen, R | 1 |
| Genovese, B | 1 |
| Miller, D | 1 |
| Hage, J | 1 |
| Jensen, K | 1 |
| Alderman, EL | 2 |
| Cullhed, I | 1 |
| Stromnes, B | 1 |
| Bailly, D | 1 |
| Servant, D | 1 |
| Blandin, N | 1 |
| Beuscart, R | 1 |
| Parquet, PJ | 1 |
| Turner, P | 2 |
| Karaush, AP | 1 |
| Gorgaslidze, AG | 1 |
| Smetnev, AS | 1 |
| Gilligan, DM | 1 |
| Chan, WL | 1 |
| Stewart, R | 1 |
| Oakley, CM | 1 |
| Katovich, MJ | 1 |
| Pitman, DL | 1 |
| Barney, CC | 1 |
| Cantopher, T | 2 |
| Olivieri, S | 2 |
| Cleave, N | 2 |
| Edwards, JG | 1 |
| Smith, DE | 1 |
| Landry, MJ | 1 |
| Edwards, G | 1 |
| Jonkman, FA | 1 |
| van Zwieten, PA | 1 |
| Rosenthal, S | 1 |
| Ellison, J | 1 |
| Krukemyer, JJ | 2 |
| Binkley, PF | 2 |
| Lima, JJ | 2 |
| Reeves, RA | 1 |
| Boer, WH | 1 |
| DeLeve, L | 1 |
| Leenen, FH | 1 |
| Baldwin, HA | 1 |
| Hitchcott, PK | 1 |
| File, SE | 1 |
| Neusy, AJ | 1 |
| Noyes, R | 1 |
| Ikola, W | 1 |
| Ugriumova, MO | 1 |
| Lennane, KJ | 1 |
| Vanholder, R | 1 |
| Lamiere, N | 1 |
| Ringoir, S | 1 |
| Moodley, P | 2 |
| Araya, R | 1 |
| Golden, RN | 1 |
| Hoffman, J | 1 |
| Falk, D | 1 |
| Provenzale, D | 1 |
| Curtis, TE | 1 |
| Dai, DZ | 3 |
| Xie, JZ | 1 |
| Liu, CF | 1 |
| Wang, ZN | 1 |
| Kuang, LX | 1 |
| Chen, L | 1 |
| Huang, ML | 1 |
| Zhang, DL | 1 |
| Zhang, XA | 1 |
| Croft, CH | 1 |
| Rude, RE | 1 |
| Gustafson, N | 1 |
| Stone, PH | 1 |
| Poole, WK | 1 |
| Roberts, R | 1 |
| Strauss, HW | 1 |
| Raabe, DS | 1 |
| Thomas, LJ | 1 |
| Jaffe, AS | 1 |
| Lee, SS | 1 |
| Braillon, A | 1 |
| Girod, C | 1 |
| Geoffroy, P | 1 |
| al-Qassab, H | 1 |
| Cleeves, LA | 1 |
| Francis, PL | 1 |
| al-Sereiti, MR | 1 |
| Findley, L | 1 |
| Hedges, A | 1 |
| Silman, R | 1 |
| Ge, J | 1 |
| Zhang, LH | 1 |
| Jin, L | 1 |
| Ananth, J | 1 |
| Lin, KM | 1 |
| Khurmi, NS | 1 |
| Raftery, EB | 1 |
| Kaneto, H | 1 |
| Kaneda, H | 1 |
| Kawatani, S | 1 |
| Lader, M | 1 |
| Ginsberg, HN | 1 |
| Jouvent, R | 1 |
| Baruch, P | 1 |
| Simon, P | 1 |
| McMahon, T | 1 |
| Wexler, BC | 1 |
| Grosz, HJ | 2 |
| Lowenstein, H | 1 |
| Goldstein, DB | 1 |
| Jhamandas, K | 1 |
| Sutak, M | 1 |
| Bell, S | 1 |
| Whitlock, FA | 1 |
| Price, J | 1 |
| Cicero, TJ | 1 |
| Meyer, ER | 1 |
| Bell, RD | 1 |
| Wettach, GE | 2 |
| Hollister, LE | 1 |
| Prusmack, JJ | 1 |
| Friedman, AP | 1 |
| Hansson, L | 2 |
| Hunyor, SN | 2 |
| Julius, S | 1 |
| Hoobler, SW | 2 |
| Harrison, TS | 1 |
| Drew, LR | 1 |
| Moon, JR | 1 |
| Buchanan, FH | 1 |
| Kersh, ES | 1 |
| Osnes, JB | 1 |
| Diaz, RG | 1 |
| Somberg, J | 1 |
| Freeman, E | 1 |
| Levitt, B | 1 |
| Martin, WR | 1 |
| Eades, CG | 1 |
| Thompson, WO | 1 |
| Thompson, JA | 1 |
| Flanary, HG | 1 |
| Johansson, T | 1 |
| MacKinnon, J | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Double-Blind, Placebo Controlled Trial of Propranolol and Amantadine for the Treatment of Cocaine Dependent Subjects With Severe Cocaine Withdrawal Symptoms[NCT00158132] | Phase 2 | 199 participants (Actual) | Interventional | 1999-09-30 | Completed | ||
| A Safe Ketamine-Based Therapy for Treatment Resistant Depression[NCT01179009] | 20 participants (Actual) | Interventional | 2012-04-30 | Completed | |||
| [NCT00000493] | Phase 3 | 0 participants | Interventional | 1977-09-30 | Completed | ||
| Conditioning & Open-Label Placebo (COLP) for Opioid Management in Intensive Inpatient Rehabilitation[NCT05351333] | 66 participants (Anticipated) | Interventional | 2022-08-03 | Recruiting | |||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
The Montgomery-Asberg Depression Rating Scale (MADRS) is a 10-item scale that measures the severity of depression, with a higher score indicating a higher level of depression. The range of scores is 0 to 60. (NCT01179009)
Timeframe: 8 weeks
| Intervention | Scores on a scale (Mean) |
|---|---|
| Ketamine 100-hour Infusion | -9.0 |
| Ketamine 40-minute Infusion | -6.4 |
26 reviews available for propranolol and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Withdrawal syndromes and the cessation of antihypertensive therapy.
Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clonidine; Humans; Hypertension; Propranolol; | 1981 |
[Use of beta-adrenergic blockers in neurologic and psychiatric clinical practice].
Topics: Adrenergic beta-Antagonists; Alcoholism; Anti-Anxiety Agents; Cardiovascular Diseases; Humans; Hyper | 1981 |
The syndrome associated with the withdrawal of beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Catecholamines; Humans; Platelet Aggregation; Propranolol; Receptors, A | 1982 |
Up and down regulation: clinical significance of nervous system receptor-drug interactions.
Topics: Anti-Anxiety Agents; Antidepressive Agents; Benzodiazepines; Dyskinesia, Drug-Induced; Humans; Nervo | 1982 |
The beta-adrenergic blockade withdrawal phenomenon.
Topics: Adrenergic beta-Antagonists; Animals; Catecholamines; Humans; Platelet Aggregation; Propranolol; Rec | 1983 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
[Withdrawal phenomena after chronic beta-blockade. Causes and therapeutic consequences].
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Calcium Channel Blockers; Coronary Disease; Death | 1984 |
[Beta-blocker withdrawal syndrome].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Arrhythmias, Cardiac; Catecholamines; Coronar | 1984 |
The beta-adrenergic blockade withdrawal phenomenon.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Catecholamines; Heart Rate; Humans; Hypertension; Plat | 1983 |
[Complications associated with sudden withdrawal of various drugs used in the treatment of cardiovascular diseases].
Topics: Cardiovascular Diseases; Clonidine; Guanethidine; Humans; Nitroglycerin; Nitroprusside; Propranolol; | 1981 |
Drug withdrawal syndromes-- a literature review.
Topics: Adrenal Cortex Hormones; Anticoagulants; Anticonvulsants; Clonidine; Ethanol; Female; Humans; Infant | 1980 |
Adjunctive treatment of benzodiazepine discontinuation syndromes: a review.
Topics: Anti-Anxiety Agents; Benzodiazepines; Carbamazepine; Clonidine; Combined Modality Therapy; Humans; P | 1993 |
Receptors, neurotransmitters and drug responses.
Topics: Animals; Antipsychotic Agents; Behavior; Brain Chemistry; Cyclic AMP; Dyskinesia, Drug-Induced; Enke | 1979 |
Antianxiety drugs in alcohol withdrawal.
Topics: Alcoholism; Anti-Anxiety Agents; Benzodiazepines; Ethanol; Haloperidol; Humans; Lithium; Propranolol | 1978 |
The effect of chronic ethanol administration on central neurotransmitter mechanisms.
Topics: 4-Butyrolactone; Animals; Aromatic-L-Amino-Acid Decarboxylases; Behavior, Animal; Brain; Catecholami | 1979 |
Beta-blockade withdrawal.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Humans; Myocardial Infarctio | 1975 |
Propranolol in the treatment of alchoholism: a review.
Topics: Alcoholism; Cardiac Output; Humans; Propranolol; Stress, Psychological; Substance Withdrawal Syndrom | 1976 |
Drug therapy: clonidine, a new antihypertensive drug.
Topics: Blood Pressure; Brain; Clonidine; Drug Interactions; Drug Therapy, Combination; Hemodynamics; Humans | 1975 |
Benzodiazepine dependency discontinuation: focus on the chemical dependency detoxification setting and benzodiazepine-polydrug abuse.
Topics: Anti-Anxiety Agents; Benzodiazepines; Dose-Response Relationship, Drug; Drug Administration Schedule | 1990 |
Beta-adrenergic blocking drugs in anxiety and stress.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Asthma; Benzodiazepine | 1985 |
[State of the adrenoreceptor system and drug therapy].
Topics: Adrenergic beta-Agonists; Animals; Asthma; Dobutamine; Ethanolamines; Humans; Mice; Propranolol; Rat | 1985 |
Treatment of benzodiazepine dependence.
Topics: Aged; Animals; Anti-Anxiety Agents; Anxiety; Benzodiazepines; Cats; Drug Tolerance; Epilepsy; Female | 1986 |
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten | 1988 |
[Practical aspects of the clinical management of benzodiazepine dependence].
Topics: Antipsychotic Agents; Benzodiazepines; Clonixin; Humans; Propranolol; Psychotherapy; Substance Withd | 1988 |
Propranolol in psychiatry. Therapeutic uses and side effects.
Topics: Adolescent; Adult; Anxiety Disorders; Central Nervous System Diseases; Child; Clinical Trials as Top | 1986 |
Use of beta-adrenergic receptor blocking drugs in psychiatry.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alcoholism; Anxiety; Chlordiazepoxide; Di | 1974 |
38 trials available for propranolol and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
The effect of propranolol on cognitive flexibility and memory in acute cocaine withdrawal.
Topics: Acute Disease; Adaptation, Psychological; Adrenergic beta-Antagonists; Adult; Cocaine-Related Disord | 2007 |
Effects of stress on decision-making deficits in formerly heroin-dependent patients after different durations of abstinence.
Topics: Adrenergic beta-Antagonists; Adult; Case-Control Studies; Decision Making; Female; Heroin Dependence | 2011 |
A double-blind, placebo-controlled trial of amantadine, propranolol, and their combination for the treatment of cocaine dependence in patients with severe cocaine withdrawal symptoms.
Topics: Adrenergic beta-Antagonists; Adult; Amantadine; Analgesics, Non-Narcotic; Cocaine; Cocaine-Related D | 2006 |
Cardiovascular effects of propranolol in patients with alcohol dependence during withdrawal.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Cardiovascular System; Ethanol; Heart Rate; Huma | 2007 |
Benzodiazepine withdrawal symptoms and propranolol.
Topics: Anti-Anxiety Agents; Diazepam; Humans; Lorazepam; Placebos; Propranolol; Substance Withdrawal Syndro | 1981 |
Psychiatric uses of antiadrenergic and adrenergic blocking drugs.
Topics: Adult; Alcohol Amnestic Disorder; Antipsychotic Agents; Bipolar Disorder; Clinical Trials as Topic; | 1984 |
Beta-blockers in psychiatry.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety Disorders; Benzodiazepines; Clinical Trial | 1984 |
Prevention of propranolol withdrawal mechanism by prolonged small dose propranolol schedule.
Topics: Adult; Aged; Blood Pressure; Dose-Response Relationship, Drug; Drug Administration Schedule; Epineph | 1982 |
Effect on finger tremor of withdrawal of long-term treatment with propranolol or atenolol.
Topics: Atenolol; Blood Pressure; Female; Fingers; Humans; Male; Middle Aged; Physical Exertion; Posture; Pr | 1984 |
Comparative effects of abrupt withdrawal of propranolol and verapamil in angina pectoris.
Topics: Angina Pectoris; Blood Pressure; Calcium Channel Blockers; Catecholamines; Clinical Trials as Topic; | 1982 |
Propranolol-associated confused states during alcohol withdrawal.
Topics: Adult; Confusion; Ethanol; Hallucinations; Humans; Male; Middle Aged; Propranolol; Psychoses, Substa | 1983 |
Gastrointestinal bleeding after abrupt cessation of propranolol administration in cirrhosis.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Liver Cirrhosis; Propranolol; S | 1982 |
Comparison of withdrawal phenomena after propranolol, metoprolol, and pindolol.
Topics: Adult; Aged; Blood Pressure; Heart Rate; Humans; Hypertension; Isoproterenol; Metoprolol; Middle Age | 1982 |
Effectiveness of propranolol for cocaine dependence treatment may depend on cocaine withdrawal symptom severity.
Topics: Adolescent; Adult; Anti-Anxiety Agents; Cocaine; Cocaine-Related Disorders; Double-Blind Method; Hum | 2001 |
Abrupt withdrawal of beta-blocking agents in patients with arterial hypertension. Effect on blood pressure, heart rate and plasma catecholamines and prolactin.
Topics: Adrenergic beta-Antagonists; Adult; Blood Pressure; Catecholamines; Clinical Trials as Topic; Female | 1979 |
Beta-blockade withdrawal.
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Clinical Trials as Topic; Humans; Myocardial Infarctio | 1975 |
Letter: Propranolol-decreased noradrenaline excretion and alcohol withdrawal.
Topics: Alcoholism; Dose-Response Relationship, Drug; Humans; Male; Norepinephrine; Placebos; Propranolol; S | 1976 |
Evaluation of propranolol in opiate dependence.
Topics: Adult; Clinical Trials as Topic; Heroin; Heroin Dependence; Humans; Hydromorphone; Male; Propranolol | 1976 |
Beta-blocker withdrawal syndrome.
Topics: Heart Rate; Humans; Hyperthyroidism; Nifedipine; Nitrites; Posture; Propranolol; Substance Withdrawa | 1979 |
beta-Blockade therapy for supraventricular tachyarrhythmias after coronary surgery: a propranolol withdrawal syndrome?
Topics: Coronary Artery Bypass; Female; Humans; Male; Postoperative Complications; Propranolol; Substance Wi | 1979 |
Effect of propranolol on acute withdrawal tremor in alcoholic patients.
Topics: Acute Disease; Adult; Age Factors; Aged; Alcoholism; Clinical Trials as Topic; Drug Evaluation; Fema | 1976 |
Propranolol in the treatment of opiate dependence -- a controlled study.
Topics: Adolescent; Adult; Clinical Trials as Topic; Euphoria; Female; Heart Rate; Humans; Male; Methadone; | 1975 |
Propranolol-withdrawal rebound phenomenon. Exacerbation of coronary events after abrupt cessation of antianginal therapy.
Topics: Adult; Aged; Angina Pectoris; Clinical Trials as Topic; Coronary Disease; Death, Sudden; Female; Hum | 1975 |
Editorial: Propranolol withdrawal.
Topics: Angina Pectoris; Clinical Trials as Topic; Coronary Artery Bypass; Coronary Disease; Humans; Myocard | 1975 |
Effects of beta-blocking drugs in alcohol withdrawal: a double-blind comparative study with propranolol and diazepam.
Topics: Adrenergic beta-Antagonists; Adult; Analysis of Variance; Anxiety Disorders; Diazepam; Double-Blind | 1992 |
Chronic benzodiazepine dependence. A comparative study of abrupt withdrawal under propranolol cover versus gradual withdrawal.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Benzodiazepines; Double-Blind Method; Female; Humans; | 1990 |
Comparison of hypersensitivity to adrenergic stimulation after abrupt withdrawal of propranolol and nadolol: influence of half-life differences.
Topics: Adult; Blood Pressure; Half-Life; Heart Rate; Humans; Isoproterenol; Male; Nadolol; Propranolol; Pul | 1990 |
Beta-blockade disappearance rate predicts beta-adrenergic hypersensitivity.
Topics: Adult; Clinical Trials as Topic; Hemodynamics; Humans; Isoproterenol; Male; Nadolol; Propranolol; Ra | 1989 |
Beta-adrenergic blocking drugs in anxiety and stress.
Topics: Adrenergic beta-Antagonists; Anti-Anxiety Agents; Anxiety; Anxiety Disorders; Asthma; Benzodiazepine | 1985 |
Therapeutic effect and complication profile of clonidine-beta-blocker combinations.
Topics: Adrenergic beta-Antagonists; Cardiovascular Diseases; Clonidine; Drug Combinations; Humans; Hyperten | 1988 |
Abrupt withdrawal of beta-blockade therapy in patients with myocardial infarction: effects on infarct size, left ventricular function, and hospital course.
Topics: Aged; Ambulatory Care; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Creatine Kinase; D | 1986 |
Is there a central nervous withdrawal syndrome associated with discontinuing long-term treatment with propranolol?
Topics: Adult; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Male; Placebos; Propranolol; | 1988 |
Propranolol in psychiatry. Therapeutic uses and side effects.
Topics: Adolescent; Adult; Anxiety Disorders; Central Nervous System Diseases; Child; Clinical Trials as Top | 1986 |
Narcotic withdrawal symptoms in heroin users treated with propranolol.
Topics: Acute Disease; Administration, Oral; Adolescent; Adult; Clinical Trials as Topic; Female; Heroin; Hu | 1972 |
Effect of propranolol on active users of heroin.
Topics: Adult; Clinical Trials as Topic; Heroin; Heroin Dependence; Humans; Placebos; Propranolol; Substance | 1973 |
Propranolol in withdrawal from opiates.
Topics: Adult; Chloral Hydrate; Drug Therapy, Combination; Heroin Dependence; Humans; Methadone; Narcotic An | 1974 |
Blood pressure crisis following withdrawal of clonidine (Catapres, Catapresan), with special reference to arterial and urinary catecholamine levels, and suggestions for acute management.
Topics: Adult; Blood Pressure; Catecholamines; Clonidine; Female; Humans; Hypertension; Male; Middle Aged; P | 1973 |
The psychological effects of propranolol in the abstinence phase of chronic alcoholics.
Topics: Adult; Alcoholism; Anxiety; Chlormethiazole; Chronic Disease; Clinical Trials as Topic; Diazepam; Hu | 1971 |
172 other studies available for propranolol and Substance Withdrawal Syndrome
| Article | Year |
|---|---|
Chronic Intermittent Ethanol and Acute Stress Similarly Modulate BNST CRF Neuron Activity via Noradrenergic Signaling.
Topics: Adrenergic Neurons; Animals; Corticotropin-Releasing Hormone; Ethanol; Excitatory Amino Acid Antagon | 2019 |
The effect of Midazolam and Propranolol on fear memory reconsolidation in ethanol-withdrawn rats: influence of d-cycloserine.
Topics: Amygdala; Animals; Anti-Anxiety Agents; Central Nervous System Depressants; Conditioning, Psychologi | 2015 |
Delayed-onset of multiple cutaneous infantile hemangiomas due to propranolol: a case report.
Topics: Dose-Response Relationship, Drug; Heart Defects, Congenital; Hemangioma; Humans; Infant; Infant, New | 2015 |
An unusual cause of thyrotoxic periodic paralysis: triiodothyronine-containing weight reducing agents.
Topics: Adult; Humans; Hypokalemic Periodic Paralysis; Male; Propranolol; Substance Withdrawal Syndrome; Thy | 2009 |
Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Animals; Antidepressive Agents; Antidepre | 2009 |
Distinct profiles of anxiety and dysphoria during spontaneous withdrawal from acute morphine exposure.
Topics: Acoustic Stimulation; Analysis of Variance; Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; | 2009 |
Effects of β-adrenoceptor antagonists on alcohol drinking by alcohol-dependent rats.
Topics: Adrenergic beta-Antagonists; Alcohol Drinking; Alcoholism; Animals; Behavior, Animal; Conditioning, | 2010 |
Effects of prazosin, clonidine, and propranolol on the elevations in brain reward thresholds and somatic signs associated with nicotine withdrawal in rats.
Topics: Adrenergic alpha-1 Receptor Antagonists; Adrenergic alpha-2 Receptor Agonists; Adrenergic beta-Antag | 2010 |
Reversal of cocaine withdrawal-induced anxiety by ondansetron, buspirone and propranolol.
Topics: Animals; Anti-Anxiety Agents; Anxiety; Behavior, Animal; Buspirone; Cocaine; Male; Motor Activity; O | 2012 |
Differential effect of beta-adrenergic receptor antagonism in basolateral amygdala on reconsolidation of aversive and appetitive memories associated with morphine in rats.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Amygdala; Analysis of Variance; Animals; | 2014 |
Morphine withdrawal activates hypothalamic-pituitary-adrenal axis and heat shock protein 27 in the left ventricle: the role of extracellular signal-regulated kinase.
Topics: Adrenergic beta-Antagonists; Adrenocorticotropic Hormone; Aminoacetonitrile; Animals; Catechol O-Met | 2012 |
Involvement of noradrenergic system within the central nucleus of the amygdala in naloxone-precipitated morphine withdrawal-induced conditioned place aversion in rats.
Topics: Adrenergic beta-Antagonists; Amygdala; Animals; Avoidance Learning; Butoxamine; Conditioning, Operan | 2003 |
Alcohol withdrawal changes cardiovascular responses to propranolol challenge.
Topics: Adrenergic beta-Antagonists; Adult; Cardiac Output; Ethanol; Heart Rate; Humans; Male; Propranolol; | 2003 |
Management of drug and alcohol withdrawal.
Topics: Adrenergic beta-Antagonists; Carbazoles; Carvedilol; Cocaine; Humans; Propanolamines; Propranolol; S | 2003 |
Changes in c-fos expression in the rat heart during morphine withdrawal. Involvement of alpha2-adrenoceptors.
Topics: Adrenergic alpha-2 Receptor Antagonists; Animals; Blotting, Western; Body Weight; Drug Administratio | 2004 |
The search for medications to treat stimulant dependence.
Topics: Amphetamine-Related Disorders; Benzhydryl Compounds; Brain; Bupropion; Cocaine; Cocaine-Related Diso | 2008 |
Beta-adrenergic coupled phospholipid methylation. A possible role in withdrawal from chronic ethanol.
Topics: Alcoholism; Animals; Cerebral Cortex; Epinephrine; Ethanol; Humans; Isoproterenol; Kinetics; Male; M | 1984 |
The phenomenon of beta-adrenergic hypersensitivity following propranolol withdrawal studied in normal subjects.
Topics: Adult; Blood Pressure; Double-Blind Method; Female; Heart Rate; Humans; Male; Physical Exertion; Pro | 1984 |
Elevation of beta-adrenergic receptor density in human lymphocytes after propranolol administration.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Adult; Blood Pressure; Female; Heart Rate; Hu | 1980 |
Factors relating to the beta blocker withdrawal syndrome.
Topics: Acebutolol; Adrenergic beta-Antagonists; Atenolol; Coronary Disease; Heart Rate; Humans; Hyperthyroi | 1981 |
Withdrawal of beta-blocking drugs.
Topics: Adrenergic beta-Antagonists; Adult; Atenolol; Heart Rate; Humans; Isoproterenol; Male; Middle Aged; | 1982 |
Comparison of withdrawal phenomena after propranolol, metoprolol and pindolol.
Topics: Adrenergic beta-Antagonists; Adult; Aged; Blood Pressure; Heart Rate; Humans; Metoprolol; Middle Age | 1982 |
[Withdrawal of preparations blocking beta-adrenergic receptors].
Topics: Adrenergic beta-Antagonists; Angina Pectoris; Animals; Catecholamines; Coronary Disease; Dose-Respon | 1982 |
Effect of withdrawal from chronic propranolol treatment on high-affinity choline uptake in rat brain.
Topics: Animals; Brain; Choline; Humans; Male; Propranolol; Rats; Rats, Inbred Strains; Reserpine; Substance | 1983 |
[Rebound reaction after beta-adrenergic blockers].
Topics: Adrenergic beta-Antagonists; Animals; Guinea Pigs; Humans; Propranolol; Rabbits; Substance Withdrawa | 1983 |
Use of beta-blocking drugs in withdrawal states.
Topics: Anti-Anxiety Agents; Benzodiazepines; Ethanol; Humans; Narcotics; Propranolol; Substance Withdrawal | 1984 |
beta-adrenergic supersensitivity in rat brainstem during clonidine withdrawal.
Topics: Animals; Brain Stem; Clonidine; Cyclic AMP; Dihydroalprenolol; Humans; Isoproterenol; Male; Proprano | 1980 |
Sustained cardiac beta adrenoceptor blockade in vitro and increased vulnerability to aconitine-induced arrhythmias in vivo after propranolol withdrawal in rats.
Topics: Aconitine; Animals; Arrhythmias, Cardiac; Body Weight; Eating; Heart; Humans; Male; Norepinephrine; | 1980 |
Changes of cyclic AMP concentration to isoproterenol after abrupt cessation of propranolol in rats.
Topics: Animals; Cyclic AMP; Humans; Isoproterenol; Male; Myocardium; Oxygen; Propranolol; Rats; Receptors, | 1980 |
Propranolol withdrawal supersensitivity in rat cardiovascular tissue, in vitro.
Topics: Animals; Cardiovascular System; Heart Rate; Humans; In Vitro Techniques; Male; Muscle, Smooth, Vascu | 1983 |
Comparison of changes in the characteristics of beta-adrenoceptors and responsiveness of human circulating lymphocytes during and after chronic administration of pindolol and propranolol.
Topics: Adult; Cell Membrane; Cyclic AMP; Dihydroalprenolol; Humans; Isoproterenol; Lymphocytes; Male; Pindo | 1984 |
Biochemical and physiological adaptation to chronic propranolol treatment in the rat.
Topics: Adaptation, Physiological; Adenylyl Cyclases; Animals; Blood Pressure; Heart Rate; Humans; Male; Myo | 1984 |
Propranolol prevents hemodynamic and humoral events after abrupt withdrawal of nitroprusside.
Topics: Adolescent; Adult; Analysis of Variance; Carbon Dioxide; Dopamine; Drug Evaluation; Epinephrine; Fem | 1984 |
Propranolol for the treatment of diazepam withdrawal symptoms.
Topics: Adult; Diazepam; Female; Humans; Male; Middle Aged; Propranolol; Substance Withdrawal Syndrome | 1984 |
Propranolol withdrawal and variceal hemorrhage.
Topics: Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Humans; Hypertension; Male; Middle Aged | 1983 |
Effects of central monoamine compounds on tranylcypromine-induced barbital-withdrawal convulsions.
Topics: alpha-Methyltyrosine; Animals; Barbital; Barbiturates; Dose-Response Relationship, Drug; Humans; Mal | 1983 |
[Human pharmacology of carteolol].
Topics: Administration, Oral; Blood Platelets; Carteolol; Coronary Disease; Hemodynamics; Humans; Hypertensi | 1983 |
Effects of propranolol on barbital dependence formation and withdrawal signs.
Topics: Animals; Anticonvulsants; Barbital; Barbiturates; Drug Interactions; Humans; Male; Propranolol; Rats | 1983 |
Propranolol withdrawal-induced supersensitivity to the chronotropic effects of isoproterenol in the conscious rabbit.
Topics: Animals; Dose-Response Relationship, Drug; Female; Heart Rate; Humans; Isoproterenol; Male; Proprano | 1983 |
Ventricular fibrillation threshold during propranolol withdrawal: an experimental study in dogs.
Topics: Animals; Dogs; Humans; Propranolol; Substance Withdrawal Syndrome; Ventricular Fibrillation | 1983 |
Hypersensitivity to the tremorogenic action of nicotine in rats withdrawn from ethanol.
Topics: Animals; Ethanol; Humans; Male; Nicotine; Propranolol; Rats; Rats, Inbred Strains; Substance Withdra | 1983 |
Acute alcohol withdrawal complicated by supraventricular tachycardia: treatment with intravenous propranolol.
Topics: Diazepam; Ethanol; Humans; Infusions, Parenteral; Male; Middle Aged; Propranolol; Substance Withdraw | 1984 |
Propranolol in the treatment of rage and violent behavior associated with Korsakoff's psychosis.
Topics: Adult; Alcohol Amnestic Disorder; Anger; Ethanol; Humans; Male; Propranolol; Rage; Receptors, Adrene | 1984 |
Massive doses of nitroglycerin in a patient with variant angina.
Topics: Angina Pectoris; Angina Pectoris, Variant; Blood Pressure; Cardiopulmonary Bypass; Coronary Disease; | 1980 |
Variations in drug free fraction during alcohol withdrawal.
Topics: Adult; Chemical Fractionation; Diazepam; Ethanol; Fatty Acids; Humans; Male; Middle Aged; Orosomucoi | 1983 |
Clonidine withdrawal complicated by amitriptyline therapy.
Topics: Aged; Amitriptyline; Anxiety; Clonidine; Female; Humans; Hypertension; Intraoperative Care; Methyldo | 1983 |
Abstinence syndrome from therapeutic doses of oxazepam.
Topics: Adult; Anxiety; Depression; Depressive Disorder; Diazepam; Fasciculation; Fear; Humans; Male; Oxazep | 1983 |
Propranolol withdrawal. Practical considerations.
Topics: Administration, Oral; Cardiovascular Diseases; Coronary Artery Bypass; Humans; Injections, Intraveno | 1981 |
Sclerosing peritonitis and propranolol.
Topics: Angina Pectoris; Colon; Gastrointestinal Hemorrhage; Humans; Hypertension; Male; Middle Aged; Perito | 1981 |
Propranolol and chlordiazepoxide effects on cardiac arrhythmias during alcohol withdrawal.
Topics: Alcoholism; Arrhythmias, Cardiac; Chlordiazepoxide; Electroencephalography; Humans; Male; Propranolo | 1980 |
Panic.
Topics: Adult; Anxiety Disorders; Cardiovascular Diseases; Endocrine System Diseases; Fear; Female; Humans; | 1982 |
The use of propranolol as a method to manage acute alcohol detoxification.
Topics: Female; Humans; Male; Propranolol; Substance Withdrawal Syndrome | 1982 |
Barbiturate dependence in mice: effects of propranolol on the withdrawal syndrome.
Topics: Animals; Barbiturates; Disease Models, Animal; Humans; Isomerism; Male; Mice; Mice, Inbred C57BL; Pr | 1980 |
Reduction in the number of serotonin receptors in the brainstem of morphine dependent rats: relation to blockade of naloxone precipitated jumping by serotonin agonists.
Topics: Animals; Behavior, Animal; Brain Stem; Clonidine; Haloperidol; Humans; Male; Morphine Dependence; Na | 1980 |
Myocardial electrical instability after abrupt withdrawal of long-term administration of propranolol to guinea pigs.
Topics: Animals; Arrhythmias, Cardiac; Guinea Pigs; Humans; In Vitro Techniques; Male; Perfusion; Propranolo | 1980 |
The effect of propranolol on the electroencephalogram in normal and ethanol dependent rats.
Topics: Alcoholism; Animals; Brain; Electroencephalography; Humans; Male; Propranolol; Rats; Substance Withd | 1980 |
Withdrawal from chronic treatment with metergoline, dl-propranolol and amitriptyline enhances serotonin receptor mediated behaviour in the rat.
Topics: Amitriptyline; Animals; Behavior, Animal; Clomipramine; Ergolines; Humans; Iprindole; Male; Metergol | 1982 |
Treatment of diazepam withdrawal syndrome with propranolol.
Topics: Adult; Diazepam; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Pro | 1981 |
A comparison of circulatory responsiveness following the sudden withdrawal from atenolol and propranolol.
Topics: Adult; Atenolol; Blood Pressure; Catecholamines; Heart Rate; Hemodynamics; Humans; Male; Physical Ex | 1981 |
[Effect of withdrawal of propranolol treatment on the heart rate in Valsalva's maneuver in patients with functional cardiovascular disorders].
Topics: Adult; Coronary Disease; Heart Rate; Humans; Male; Myocardial Contraction; Propranolol; Substance Wi | 1980 |
The effect of propranolol withdrawal on thyroid hormones in normal and hyperthyroid subjects.
Topics: Adult; Female; Humans; Hyperthyroidism; Male; Middle Aged; Propranolol; Substance Withdrawal Syndrom | 1980 |
Noncardiac surgery in patients receiving propranolol. Case reports and recommended approach.
Topics: Anesthesia, General; Aorta, Abdominal; Aorta, Thoracic; Aortic Aneurysm; Cardiovascular Diseases; Hu | 1981 |
Beta-adrenergic antagonists attenuate withdrawal anxiety in cocaine- and morphine-dependent rats.
Topics: Adrenergic beta-Antagonists; Animals; Anxiety; Atenolol; Cocaine; Injections, Intraperitoneal; Male; | 1993 |
Beta-adrenergic antagonists attenuate somatic and aversive signs of opiate withdrawal.
Topics: Adrenergic beta-Antagonists; Animals; Atenolol; Avoidance Learning; Male; Naloxone; Narcotics; Propr | 1993 |
A study on withdrawal related haemodynamic response in chronic propranolol treated conscious rats.
Topics: Animals; Blood Pressure; Heart Rate; Hypertension; Male; Propranolol; Rats; Rats, Wistar; Substance | 1993 |
Study of the mechanisms involved in behavioral changes induced by flunitrazepam in morphine withdrawal.
Topics: Animals; Behavior, Animal; Dogs; Dose-Response Relationship, Drug; Flunitrazepam; Male; Mice; Mice, | 1995 |
Nicotine attenuates naloxone-induced jumping behaviour in morphine-dependent mice.
Topics: Animals; Atropine; Behavior, Animal; Benzazepines; Hexamethonium; Male; Mecamylamine; Mice; Morphine | 1996 |
On the mechanism(s) of cholecystokinin (CCK): receptor stimulation attenuates morphine dependence in mice.
Topics: Adrenergic Antagonists; Animals; Atropine; Benzazepines; Ceruletide; Dopamine Antagonists; Male; Met | 1997 |
[Case of hypertrophic cardiomyopathy with ventricular blood flow disparity after withdrawal of adrenergic beta antagonists].
Topics: Adrenergic beta-Antagonists; Aged; Blood Flow Velocity; Cardiomyopathy, Hypertrophic; Humans; Male; | 1997 |
Mechanism-based modeling of rebound tachycardia after chronic l-propranolol infusion in spontaneous hypertensive rats.
Topics: Adrenergic beta-Antagonists; Algorithms; Animals; Chromatography, High Pressure Liquid; Half-Life; H | 1999 |
The bed nucleus of the stria terminalis. A target site for noradrenergic actions in opiate withdrawal.
Topics: Amygdala; Animals; Axonal Transport; Caudate Nucleus; Male; Microinjections; Morphine Dependence; Na | 1999 |
Noradrenaline in the ventral forebrain is critical for opiate withdrawal-induced aversion.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Amygdala; Animals; Betaxolol; Clonidine; Mal | 2000 |
Migraine with prolonged aura.
Topics: Adult; Humans; Male; Migraine with Aura; Propranolol; Substance Withdrawal Syndrome; Time Factors | 2000 |
Effect of propranolol on antinociceptive, tolerance- and dependence-producing properties of morphine in rodents and monkeys.
Topics: Analgesics, Opioid; Animals; Drug Interactions; Drug Tolerance; Female; Haplorhini; Humans; Macaca m | 1975 |
The effect of beta-adrenoreceptive antagonists on the morbidity and mortality in cardiovascular disease.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Animals; Coronary Disease; Dogs; Follow-Up | 1976 |
Labetalol (AH5158), a competitive alpha- and beta-receptor blocking drug, in the management of hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Aldosterone; Angiotensin II; Cloni | 1976 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 4. Adverse effects. Choosing a beta-adrenoreceptor blocker.
Topics: Adrenergic beta-Antagonists; Arrhythmias, Cardiac; Bronchi; Central Nervous System Diseases; Deafnes | 1979 |
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 8. Self-poisoning with beta-adrenoceptor blocking agents: recognition and management.
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Bronchial Spasm; Female; Humans; Hypoglycemia; Male; | 1979 |
Rebound effect after stopping beta-blockers.
Topics: Adrenergic beta-Antagonists; Humans; Propranolol; Substance Withdrawal Syndrome; Sympathetic Nervous | 1979 |
Beta-blockade withdrawal.
Topics: Dose-Response Relationship, Drug; Humans; Hypertension; Propranolol; Substance Withdrawal Syndrome | 1975 |
Beta-blocker withdrawal syndrome?
Topics: Atenolol; Humans; Male; Metoprolol; Propanolamines; Propranolol; Substance Withdrawal Syndrome | 1979 |
Beta-blocker withdrawal syndrome.
Topics: Humans; Metoprolol; Nifedipine; Propanolamines; Propranolol; Pyridines; Substance Withdrawal Syndrom | 1979 |
Hypersensitivity to adrenergic stimulation after propranolol withdrawal in normal subjects.
Topics: Administration, Oral; Adult; Heart Rate; Humans; Hypersensitivity; Isoproterenol; Myocardial Contrac | 1977 |
Changes in receptor sensitivity of the cerebral cortex and liver during chronic ethanol ingestion and withdrawal.
Topics: Alcoholism; Animals; Brain; Cyclic AMP; Humans; Liver; Male; Norepinephrine; Propranolol; Rats; Rece | 1977 |
Abrupt withdrawal of cardiovascular drugs.
Topics: Cardiovascular Agents; Clonidine; Hemodynamics; Homeostasis; Humans; Nitroglycerin; Nitroprusside; P | 1979 |
Beta-blocker withdrawal syndrome.
Topics: Heart; Humans; Propranolol; Receptors, Adrenergic, beta; Substance Withdrawal Syndrome; Sympathetic | 1979 |
Continuing propranolol preop benefits coronary bypass patients.
Topics: Coronary Artery Bypass; Humans; Preoperative Care; Propranolol; Substance Withdrawal Syndrome | 1978 |
Beneficial effect of continuation of propranolol through coronary bypass surgery.
Topics: Adult; Coronary Artery Bypass; Depression, Chemical; Epinephrine; Heart Rate; Humans; Middle Aged; M | 1979 |
Propranolol withdrawal in angina pectoris: a prospective study.
Topics: Adult; Aged; Angina Pectoris; Cardiovascular System; Female; Humans; Male; Middle Aged; Propranolol; | 1979 |
The nature and etiology of normal and alcohol withdrawal tremor.
Topics: Alcoholism; Biomechanical Phenomena; Electromyography; Female; Humans; Male; Posture; Propranolol; S | 1979 |
Mechanism of propranolol withdrawal phenomena.
Topics: Adult; Aged; Blood Pressure; Catecholamines; Electrocardiography; Female; Heart Rate; Humans; Isopro | 1979 |
Additional side effects of propranolol.
Topics: Humans; Male; Propranolol; Substance Withdrawal Syndrome; Syndrome | 1979 |
Fatal rebound hypertension after abrupt withdrawal of clonidine and propranolol.
Topics: Clonidine; Humans; Hypertension; Male; Middle Aged; Propranolol; Substance Withdrawal Syndrome | 1979 |
Changes in blood pressure, heart rate, and plasma noradrenaline concentration after sudden withdrawal of propranolol.
Topics: Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Norepinephrine; Propranolol; Substan | 1979 |
[Propranolol withdrawal syndrome].
Topics: Coronary Vessels; Humans; Platelet Aggregation; Propranolol; Substance Withdrawal Syndrome; Syndrome | 1979 |
The pathogenesis of propranolol-withdrawal syndrome in essential hypertension.
Topics: Adult; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol; Substance Withdrawa | 1979 |
Prevention of ethanol withdrawal seizures in mice by local anesthetics and dextro-propranolol.
Topics: Anesthetics, Local; Animals; Ataxia; Behavior, Animal; Ethanol; Female; Humans; Mice; Mice, Inbred C | 1977 |
Hemodynamic and metabolic response after abrupt uithdrawal of long-term propranolol.
Topics: Animals; Blood Pressure; Dogs; Epinephrine; Fatty Acids, Nonesterified; Female; Heart; Heart Rate; H | 1978 |
Cerebral blood flow and oxygen consumption during ethanol withdrawal in the rat.
Topics: Adrenal Glands; Adrenalectomy; Alcoholism; Animals; Brain; Carbon Dioxide; Cerebrovascular Circulati | 1979 |
Caution in propranolol withdrawal.
Topics: Acute Disease; Angina Pectoris; Humans; Myocardial Infarction; Propranolol; Substance Withdrawal Syn | 1977 |
Hyperthyroidism after propranolol withdrawal.
Topics: Adult; Female; Humans; Hyperthyroidism; Male; Middle Aged; Propranolol; Substance Withdrawal Syndrom | 1977 |
Withdrawal of antihypertensive therapy. Hypertensive crisis in renovascular hypertension.
Topics: Acute Disease; Aged; Blood Pressure; Clonidine; Diuretics; Female; Humans; Hypertension, Malignant; | 1977 |
Comparative efficacy of propranolol and chlordiazepoxide in alcohol withdrawal.
Topics: Adult; Alcoholism; Catecholamines; Chlordiazepoxide; Dose-Response Relationship, Drug; Drug Evaluati | 1977 |
Sinus tachycardis in a hypertensive patient: drug withdrawal phenomenon?
Topics: Arrhythmia, Sinus; Female; Humans; Hydralazine; Hypertension; Middle Aged; Propranolol; Substance Wi | 1977 |
Blood pressure rebound following withdrawal of antihypertensive treatment.
Topics: Blood Pressure; Clonidine; Humans; Hypertension, Renal; Propranolol; Recurrence; Substance Withdrawa | 1978 |
Propranolol in the treatment of cardiovascular disease.
Topics: Angina Pectoris; Aortic Aneurysm; Aortic Dissection; Arrhythmias, Cardiac; Cardiomyopathies; Cardiov | 1978 |
Propranolol rebound--a retrospective study.
Topics: Adult; Aged; Cardiac Catheterization; Coronary Disease; Female; Hospitalization; Humans; Male; Middl | 1978 |
Propranolol withdrawal and thyroid hormones in patients with essential hypertension.
Topics: Adult; Blood Pressure; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Propranolol; Sub | 1978 |
Withdrawal of antihypertensive therapy.
Topics: Animals; Clonidine; Drug Therapy, Combination; Humans; Hypertension, Renal; Propranolol; Substance W | 1978 |
Pulling the therapeutic rug.
Topics: Anticoagulants; Blood Coagulation Disorders; Clonidine; Humans; Propranolol; Risk; Substance Withdra | 1978 |
Propranolol withdrawal syndrome - why?
Topics: Blood Platelets; Humans; Platelet Aggregation; Propranolol; Substance Withdrawal Syndrome | 1978 |
Chronic hemodynamic effects of propranolol treatment in dialysis-refractory hypertension.
Topics: Adult; Blood Pressure; Cardiac Output; Electrocardiography; Female; Hemodynamics; Humans; Hypertensi | 1978 |
Alcohol intoxication and the alcohol withdrawal syndrome.
Topics: Alcoholic Intoxication; Alcoholism; Benzodiazepines; Chlordiazepoxide; Hallucinations; Humans; Pheny | 1978 |
[Sudden withdrawal of propranolol after long term use].
Topics: Coronary Disease; Humans; Propranolol; Substance Withdrawal Syndrome | 1978 |
Propranolol withdrawal.
Topics: Aged; Humans; Male; Middle Aged; Propranolol; Substance Withdrawal Syndrome | 1978 |
Sudden withdrawal of propranolol in patients with angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Cardiovascular Diseases; Coronary Disease; Female; Humans; Male; Middl | 1977 |
[Propranolol induced increase in serum thyroxine (total T-4) in patients with essential hypertension].
Topics: Adult; Female; Humans; Hypertension; Hyperthyroidism; Male; Middle Aged; Propranolol; Substance With | 1977 |
Abrupt propranolol withdrawal.
Topics: Heart Rate; Humans; Propranolol; Substance Withdrawal Syndrome | 1977 |
Prevention of some complications of essential hypertension.
Topics: Anesthesia; Antihypertensive Agents; Arteriosclerosis; Clonidine; Diabetes Complications; Drug Incom | 1977 |
Acute coronary syndromes following abrupt cessation of oral propranolol therapy.
Topics: Acute Disease; Administration, Oral; Adult; Aged; Angina Pectoris; Coronary Disease; Dose-Response R | 1976 |
Effect of pharmacological interference with various neuropathways on blockade of morphine-withdrawal hypothermia by morphine and by conditional stimulus.
Topics: Animals; Benztropine; Conditioning, Classical; Cyproheptadine; Haloperidol; Humans; Hypothermia; Mal | 1976 |
Letter: Cessation of propranolol therapy and rebound angina pectoris.
Topics: Angina Pectoris; Humans; Propranolol; Substance Withdrawal Syndrome | 1976 |
Abrupt propranolol withdrawal and myocardial contractility. A study of effects in normal man.
Topics: Adolescent; Adult; Cardiac Output; Exercise Test; Female; Heart Rate; Humans; Male; Myocardial Contr | 1976 |
Letter: Propranolol withdrawal.
Topics: Adult; Angina Pectoris; Arteriosclerosis; Coronary Disease; Humans; Male; Middle Aged; Propranolol; | 1975 |
Letter: Non-compliance and propranolol withdrawal.
Topics: Humans; Patient Compliance; Propranolol; Substance Withdrawal Syndrome | 1975 |
[Propranolol in the treatment of withdrawal symptoms].
Topics: Adult; Alcoholism; Female; Humans; Male; Propranolol; Substance Withdrawal Syndrome; Substance-Relat | 1975 |
Editorial: Discontinuation of propranolol therapy. Cause of rebound angina pectoris and acute coronary events.
Topics: Angina Pectoris; Coronary Disease; Humans; Myocardial Infarction; Propranolol; Substance Withdrawal | 1976 |
[Withdrawal of beta adrenergic antagonist].
Topics: Angina Pectoris; Humans; Propranolol; Substance Withdrawal Syndrome | 1976 |
Letter: Effect of propranolol on tremor of alcohol withdrawal.
Topics: Alcoholism; Humans; Propranolol; Substance Withdrawal Syndrome; Tremor | 1976 |
[Rebound effect at abrupt withdrawal of propranolol].
Topics: Angina Pectoris; Humans; Propranolol; Substance Withdrawal Syndrome | 1976 |
Should propranolol be stopped before surgery?
Topics: Anesthetics; Angina Pectoris; Drug Synergism; Humans; Propranolol; Substance Withdrawal Syndrome; Su | 1976 |
Clinical psychopharmacology of beta-adrenoceptor antagonism in treatment of anxiety.
Topics: Adrenergic beta-Antagonists; Anxiety Disorders; Central Nervous System; Humans; Propranolol; Substan | 1991 |
[Effectiveness of single intravenous administration of cordarone, ethacizine and obsidan in ventricular extrasystole in patients with chronic alcoholism during withdrawal].
Topics: Adult; Alcoholism; Amiodarone; Anti-Arrhythmia Agents; Cardiac Complexes, Premature; Ethanol; Humans | 1991 |
Adrenergic hypersensitivity after beta-blocker withdrawal in hypertrophic cardiomyopathy.
Topics: Adult; Aged; Angina Pectoris; Atenolol; Cardiomyopathy, Hypertrophic; Coronary Disease; Drug Hyperse | 1991 |
Mechanisms mediating the thermal response to morphine withdrawal in rats.
Topics: Adrenal Glands; Adrenergic alpha-Agonists; Animals; Body Temperature; Clonidine; Female; Morphine; N | 1990 |
Benzodiazepine withdrawal.
Topics: Anti-Anxiety Agents; Benzodiazepines; Humans; Propranolol; Substance Withdrawal Syndrome; Substance- | 1990 |
Aggravation of the severity of the clonidine withdrawal syndrome in conscious rats by beta 2-adrenoceptor antagonists.
Topics: Adrenergic beta-Antagonists; Animals; Blood Pressure; Clonidine; Heart Rate; Male; Propanolamines; P | 1990 |
Propranolol withdrawal in psychosis.
Topics: Acute Disease; Adult; Female; Hallucinations; Humans; Propranolol; Psychomotor Agitation; Psychoses, | 1990 |
Biphasic pattern of hypersensitivity following acute propranolol withdrawal in normal subjects.
Topics: Adult; Blood Pressure; Heart Rate; Humans; Male; Physical Exertion; Propranolol; Substance Withdrawa | 1989 |
Evidence that the increased anxiety detected in the elevated plus-maze during chlordiazepoxide withdrawal is not due to enhanced noradrenergic activity.
Topics: Animals; Anxiety; Chlordiazepoxide; Clonidine; Learning; Male; Norepinephrine; Propranolol; Rats; Ra | 1989 |
Blood pressure and blood pressure variability following withdrawal of propranolol and clonidine.
Topics: Adult; Aged; Blood Pressure; Clonidine; Female; Humans; Hypertension; Male; Middle Aged; Propranolol | 1989 |
Ethanol withdrawal tremor potentiates the tremorogenic action of nicotine.
Topics: Animals; Ethanol; Hexamethonium; Hexamethonium Compounds; Male; Nicotine; Propranolol; Rats; Rats, I | 1985 |
Psychoses associated with propranolol withdrawal.
Topics: Aged; Delusions; Female; Humans; Middle Aged; Paranoid Disorders; Propranolol; Psychoses, Substance- | 1989 |
[Adaptive effect and withdrawal syndrome of propranolol in relation to norepinephrine and epinephrine].
Topics: Adaptation, Physiological; Animals; Epinephrine; Myocardium; Norepinephrine; Propranolol; Rats; Subs | 1985 |
[Influence of propranolol withdrawal on the induction of sudden death in chronically infarcted rats by isoproterenol challenge].
Topics: Animals; Death, Sudden; Mice; Myocardial Infarction; Propranolol; Rats; Substance Withdrawal Syndrom | 1987 |
Haemodynamic rebound phenomena after abrupt cessation of propranolol therapy in portal hypertensive rats.
Topics: Animals; Depression, Chemical; Dose-Response Relationship, Drug; Heart Rate; Hemodynamics; Hypertens | 1986 |
[Influences of propranolol on uptake and loss of norepinephrine in tissues of rats].
Topics: Animals; Female; Male; Norepinephrine; Propranolol; Rats; Rats, Inbred Strains; Substance Withdrawal | 1987 |
A comparison of nine calcium ion antagonists and propranolol: exercise tolerance, heart rate and ST-segment changes in patients with chronic stable angina pectoris.
Topics: Adult; Aged; Angina Pectoris; Calcium Channel Blockers; Chronic Disease; Electrocardiography; Female | 1987 |
Pharmacological characterization of alcohol and barbital physical dependence in mice.
Topics: Animals; Atropine; Barbital; Barbiturates; Clonidine; Ethanol; Male; Mice; Muscimol; Propranolol; Su | 1987 |
Management of benzodiazepine dependence.
Topics: Barbiturates; Benzodiazepines; Clonidine; Humans; Prognosis; Propranolol; Substance Withdrawal Syndr | 1986 |
Propranolol in the treatment of restless legs syndrome induced by imipramine withdrawal.
Topics: Depressive Disorder; Female; Humans; Imipramine; Middle Aged; Propranolol; Restless Legs Syndrome; S | 1986 |
Manic episode after propranolol withdrawal.
Topics: Bipolar Disorder; Clomipramine; Depressive Disorder; Female; Humans; Middle Aged; Propranolol; Subst | 1986 |
Bipolar affective symptoms associated with use of captopril and abrupt withdrawal of pargyline and propranolol.
Topics: Bipolar Disorder; Captopril; Drug Therapy, Combination; Female; Humans; Hypertension; Middle Aged; N | 1985 |
Prolonged protective effects following propranolol withdrawal against isoproterenol-induced myocardial infarction in normotensive and hypertensive rats.
Topics: Animals; Blood Pressure; Corticosterone; Creatine Kinase; Female; Humans; Isoproterenol; L-Lactate D | 1985 |
Propranolol in alcohol addiction.
Topics: Adrenergic beta-Antagonists; Alcoholism; Female; Humans; Propranolol; Substance Withdrawal Syndrome | 1972 |
Propranolol as a psychotropic agent.
Topics: Adolescent; Adult; Aged; Female; Humans; Mental Disorders; Propranolol; Substance Withdrawal Syndrom | 1973 |
Beta-blockade for withdrawal symptoms?
Topics: Adrenergic beta-Antagonists; Alcoholism; Humans; Propranolol; Substance Withdrawal Syndrome | 1973 |
Alcohol withdrawal reactions in mice: effects of drugs that modify neurotransmission.
Topics: 5-Hydroxytryptophan; Acetates; Aminobutyrates; Animals; Atropine; Ethanol; Fenclonine; Humans; Male; | 1973 |
Modification of precipitated morphine withdrawal syndrome by drugs affecting cholinergic mechanisms.
Topics: Animals; Atropine; Autonomic Nervous System; Diphenhydramine; Dose-Response Relationship, Drug; Drug | 1973 |
Effects of phenoxybenzamine on the narcotic withdrawal syndrome in the rat.
Topics: Adrenergic beta-Antagonists; Animals; Behavior, Animal; Body Weight; Chlorpromazine; Depression, Che | 1974 |
Coronary artery syndromes after sudden propranolol withdrawal.
Topics: Adult; Aged; Angina Pectoris; Death, Sudden; Electrocardiography; Humans; Male; Middle Aged; Myocard | 1974 |
Adrenergic supersensitivity during ethanol withdrawal in the rat.
Topics: Animals; Body Weight; Cerebral Cortex; Cyclic AMP; Diet; Drug Hypersensitivity; Ethanol; Humans; Hyp | 1973 |
Migraine headaches.
Topics: Caffeine; Contraceptives, Oral; Cyproheptadine; Diagnosis, Differential; Diuretics; Drug Combination | 1972 |
Effects of clonidine withdrawal: possible mechanisms and suggestions for management.
Topics: Blood Pressure; Catecholamines; Clonidine; Epinephrine; Heart Rate; Humans; Hypertension; Injections | 1973 |
Inderal (propranolol) in the treatment of alcoholism.
Topics: Adult; Alcoholism; Anxiety; Humans; Propranolol; Substance Withdrawal Syndrome; Tremor | 1973 |
Narcotic poisoning: an epidemic disease.
Topics: Diazepam; Glucose; Hospitalization; Humans; Hyperglycemia; Methadone; Myelitis, Transverse; Myoglobi | 1973 |
[Infarction following sudden withdrawal of propranolol].
Topics: Angina Pectoris; Humans; Myocardial Infarction; Propranolol; Substance Withdrawal Syndrome | 1973 |
Letter: Propranolol.
Topics: Diabetes Complications; Female; Heroin Dependence; Humans; Middle Aged; Propranolol; Substance Withd | 1974 |
Myocardial infarction after propranolol withdrawal.
Topics: Angina Pectoris; Animals; Arteriosclerosis; Coronary Disease; Dogs; Humans; Myocardial Infarction; N | 1974 |
Letter: Adverse reactions after propranolol withdrawal.
Topics: Cardiac Surgical Procedures; Humans; Propranolol; Substance Withdrawal Syndrome | 1974 |
Morphine physical dependence in the dog.
Topics: Animals; Behavior, Animal; Body Temperature; Body Weight; Dogs; Dose-Response Relationship, Drug; Ha | 1974 |
Propranolol and polythiazide in treatment of hypertension.
Topics: Adult; Black or African American; Blood Pressure; Bronchial Spasm; Drug Synergism; Female; Hallucina | 1972 |